Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
Principais autores: | , , , , , , , , , |
---|---|
Formato: | Conference item |
Publicado em: |
American Thoracic Society
2018
|
Resumo: |
---|